Reprogramming biological peptides to combat infectious diseases.

  title={Reprogramming biological peptides to combat infectious diseases.},
  author={Marcelo Der Torossian Torres and Cesar de la Fuente-Nunez},
  journal={Chemical Communications},
With the rapid spread of resistance among parasites and bacterial pathogens, antibiotic-resistant infections have drawn much attention worldwide. Consequently, there is an urgent need to develop new strategies to treat neglected diseases and drug-resistant infections. Here, we outline several new strategies that have been developed to counter pathogenic microorganisms by designing and constructing antimicrobial peptides (AMPs). In addition to traditional discovery and design mechanisms guided… 

Accelerating antibiotic discovery through artificial intelligence

This review describes AI-facilitated advances in the discovery of both small molecule antibiotics and antimicrobial peptides and analyzes uptake of open science best practices in AI-driven antibiotic discovery and argues for openness and reproducibility as a means of accelerating preclinical research.

Hybrid Antimicrobial Peptide Targeting Staphylococcus aureus and Displaying Anti-infective Activity in a Murine Model

This study successfully designed a targeting AMP, S2, which is a fusion peptide composed of a species-specific targeting domain and broad-spectrum AMP domain that showed specific killing activity against Staphylococcus aureus, and almost no resistance induced compared to penicillin.

A Novel Peptide Antibiotic, Pro10-1D, Designed from Insect Defensin Shows Antibacterial and Anti-Inflammatory Activities in Sepsis Models

Pro10-1D can potentially serve as a novel peptide antibiotic for the treatment of gram-negative sepsis owing to its outstanding inhibitory activities against bacterial film formation with high bacterial cell selectivity.

Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response

Synthetic peptides derived from indolicidin, a naturally occurring HDP, are designed and tested and it is concluded that these peptides inhibit VEEV replication and the inflammatory burden associated with VEEv infection.

Synthetic Peptide Derived from Scorpion Venom Displays Minimal Toxicity and Anti-infective Activity in an Animal Model.

A simple method based on net charge tuning to turn highly toxic venom-derived peptides into viable therapeutics is described, demonstrating that increased net charge significantly reduced toxicity toward human erythrocytes.

An Enhanced Variant Designed From DLP4 Cationic Peptide Against Staphylococcus aureus CVCC 546

Findings indicate that ID13 may be a promising peptide antimicrobial agent for therapeutic application.

The wasp venom antimicrobial peptide polybia‐CP and its synthetic derivatives display antiplasmodial and anticancer properties

Novel and previously undescribed functions for Polybia‐CP and analogs are revealed and it is demonstrated that by tuning these physicochemical parameters, it is possible to design synthetic peptides with enhanced submicromolar antiplasmodial potency and micromolar anticancer activity.

Bacterial Natural Compounds with Anti-Inflammatory and Immunomodulatory Properties (Mini Review)

Bacterial natural compounds with modulating effects on cytokines that are surveyed which may have potential anti-inflammatory drug-like activity are summarized.



Designing antimicrobial peptides: form follows function

Multidrug-resistant bacteria are a severe threat to public health. Conventional antibiotics are becoming increasingly ineffective as a result of resistance, and it is imperative to find new

Mimics of Host Defense Proteins; Strategies for Translation to Therapeutic Applications.

This review focuses on HDP mimetic approaches aimed to improve metabolic stability, pharmacokinetics, safety and manufacturing processes, and considerable effort has been directed at developing amphiphilic compounds that recapitulate the structural and biological properties of HDPs on small abiotic scaffolds.

Antimicrobial Peptides: An Emerging Category of Therapeutic Agents

An overview of the biological role, classification, and mode of action of AMPs is provided, the opportunities and challenges to develop these peptides for clinical applications are discussed, and the innovative formulation strategies for application are reviewed.

Antimicrobial peptides under clinical investigation

This review lists the 36 antimicrobial peptides (AMPs) under clinical investigation and categorized several improvement strategies and highlighted directions for the future design of AMPs.

Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections

This review provides an overview of the antimicrobial and immunomodulatory activities of natural host defence peptides, and discusses strategies for creating artificial derivatives with improved biological and pharmacological properties, issues of microbial resistance, and challenges associated with their adaptation for clinical use.

An anti-infective synthetic peptide with dual antimicrobial and immunomodulatory activities

The peptide presented here directly kills bacteria and further helps resolve infections through its immune modulatory properties, and represents a new approach to treat antibiotic-resistant infections.

Toward computer-made artificial antibiotics.